ID: ALA3276817

Max Phase: Preclinical

Molecular Formula: C21H25N3O

Molecular Weight: 335.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1c2ccccc2N(c2ccccc2)CCN1CCN1CCCC1

Standard InChI:  InChI=1S/C21H25N3O/c25-21-19-10-4-5-11-20(19)24(18-8-2-1-3-9-18)17-16-23(21)15-14-22-12-6-7-13-22/h1-5,8-11H,6-7,12-17H2

Standard InChI Key:  YFHLFXICDSSMQY-UHFFFAOYSA-N

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ileum 856 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 335.45Molecular Weight (Monoisotopic): 335.1998AlogP: 3.38#Rotatable Bonds: 4
Polar Surface Area: 26.79Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.41CX LogP: 3.19CX LogD: 2.14
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.86Np Likeness Score: -1.09

References

1. Bagolini C, de Witt P, Pacifici L, Ramacci MT..  (1978)  Synthesis and pharmacological activity and some derivatives of 1-phenyl-1,2,3,4-tetrahydro-5H-1,4-benzodiazepin-5-one.,  21  (5): [PMID:26804] [10.1021/jm00203a015]

Source